EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Emergent Biosolutions Inc. (EBS) EBITDA Margin data is not available.
| Income Statement Financials | |
$148.70M |
|
$-54.60M |
|
$84.90M |
|
$63.80M |
|
$176.60M |
|
$-27.90M |
|
$-22.80M |
|
$-50.70M |
|
$-50.70M |
|
$-54.60M |
|
$-54.60M |
|
$-54.60M |
|
$-54.60M |
|
$-27.90M |
|
$-1.80M |
|
53.50M |
|
56.70M |
|
$-1.01 |
|
$-0.95 |
|
| Balance Sheet Financials | |
$662.50M |
|
$205.40M |
|
$656.10M |
|
$1.32B |
|
$132.20M |
|
$572.10M |
|
$663.80M |
|
$796.00M |
|
$522.60M |
|
$86.10M |
|
$522.60M |
|
52.10M |
|
| Cash Flow Statement Financials | |
$170.60M |
|
$69.40M |
|
$-136.60M |
|
$105.60M |
|
$209.10M |
|
$103.50M |
|
$16.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.01 |
|
-- |
|
-- |
|
0.52 |
|
1.09 |
|
42.91% |
|
-18.76% |
|
-18.76% |
|
|
EBITDA Margin |
-- |
-34.10% |
|
-36.72% |
|
$195.00M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.25 |
|
1.77 |
|
50.96 |
|
-10.45% |
|
-63.41% |
|
-4.14% |
|
-4.99% |
|
$10.03 |
|
$3.44 |
|
$3.01 |
|